Tower Research Capital (TRC)’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Tower Research Capital (TRC)’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-834	Closed	-$144K	–	5653
2015 Q1	$144K	Sell	834 -486	-37%	-$71.3K	0.02%	610
2014 Q4	$152K	Buy	1,320 +1,231	+1,383%	+$149K	0.01%	406
2014 Q3	$14K	Sell	89 -4,351	-98%	-$631K	﹤0.01%	2619
2014 Q2	$548K	Buy	4,440 +3,965	+835%	+$438K	0.07%	232
2014 Q1	$49K	Sell	475 -337	-42%	-$34.5K	0.01%	1116
2013 Q4	$73K	Sell	812 -525	-39%	-$41.9K	0.01%	1081
2013 Q3	$89K	Buy	+1,337	New	+$92.1K	0.01%	1404

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Tower Research Capital (TRC)'s SLXP Position: Q2 2015 in Review

Tower Research Capital (TRC) sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 834 shares — an estimated $144K sold.

Tower Research Capital (TRC) first reported a position in SLXP in Q3 2013 and held it in 7 quarters. The position peaked at $548K in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Tower Research Capital (TRC) reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Tower Research Capital (TRC) sold 834 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $144K.
Tower Research Capital (TRC) first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 7 quarters.
Tower Research Capital (TRC)'s SALIX PHARMACEUTICALS LTD DEL position peaked at $548K in Q2 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.